IRF9 and colorectal cancer: Additionally, DOX-persisting proliferative cells marked by a U‐ISGF3-gene signature upregulate the HSH2D gene – a poor prognostic marker in colorectal cancer (Human Protein Atlas proteinatlas.org [20]).